328 related articles for article (PubMed ID: 33790780)
1. The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease.
Samadian M; Gholipour M; Hajiesmaeili M; Taheri M; Ghafouri-Fard S
Front Aging Neurosci; 2021; 13():641080. PubMed ID: 33790780
[TBL] [Abstract][Full Text] [Related]
2. miR-34a-5p and miR-125b-5p attenuate Aβ-induced neurotoxicity through targeting BACE1.
Li P; Xu Y; Wang B; Huang J; Li Q
J Neurol Sci; 2020 Jun; 413():116793. PubMed ID: 32251872
[TBL] [Abstract][Full Text] [Related]
3. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200a-3p Mediates Neuroprotection in Alzheimer-Related Deficits and Attenuates Amyloid-Beta Overproduction and Tau Hyperphosphorylation
Wang L; Liu J; Wang Q; Jiang H; Zeng L; Li Z; Liu R
Front Pharmacol; 2019; 10():806. PubMed ID: 31379578
[TBL] [Abstract][Full Text] [Related]
5. Profile of Pathogenic Proteins and MicroRNAs in Plasma-derived Extracellular Vesicles in Alzheimer's Disease: A Pilot Study.
Li F; Xie XY; Sui XF; Wang P; Chen Z; Zhang JB
Neuroscience; 2020 Apr; 432():240-246. PubMed ID: 32135232
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology.
Sierksma A; Lu A; Salta E; Vanden Eynden E; Callaerts-Vegh Z; D'Hooge R; Blum D; Buée L; Fiers M; De Strooper B
Mol Neurodegener; 2018 Oct; 13(1):54. PubMed ID: 30314521
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data.
Satoh J; Kino Y; Niida S
Biomark Insights; 2015; 10():21-31. PubMed ID: 25922570
[TBL] [Abstract][Full Text] [Related]
8. Identification of the Role of miR-142-5p in Alzheimer's Disease by Comparative Bioinformatics and Cellular Analysis.
Song J; Kim YK
Front Mol Neurosci; 2017; 10():227. PubMed ID: 28769761
[TBL] [Abstract][Full Text] [Related]
9. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
Lugli G; Cohen AM; Bennett DA; Shah RC; Fields CJ; Hernandez AG; Smalheiser NR
PLoS One; 2015; 10(10):e0139233. PubMed ID: 26426747
[TBL] [Abstract][Full Text] [Related]
10. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells.
Zhang N; Li WW; Lv CM; Gao YW; Liu XL; Zhao L
Neuroreport; 2020 Feb; 31(3):205-212. PubMed ID: 31876684
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
12. Candidate Alzheimer's Disease Biomarker miR-483-5p Lowers TAU Phosphorylation by Direct ERK1/2 Repression.
Nagaraj S; Want A; Laskowska-Kaszub K; Fesiuk A; Vaz S; Logarinho E; Wojda U
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915734
[TBL] [Abstract][Full Text] [Related]
13. Identification of miRNA-mRNA Pairs in the Alzheimer's Disease Expression Profile and Explore the Effect of miR-26a-5p/PTGS2 on Amyloid-β Induced Neurotoxicity in Alzheimer's Disease Cell Model.
Xie T; Pei Y; Shan P; Xiao Q; Zhou F; Huang L; Wang S
Front Aging Neurosci; 2022; 14():909222. PubMed ID: 35783137
[TBL] [Abstract][Full Text] [Related]
14. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective.
Rahman MR; Islam T; Zaman T; Shahjaman M; Karim MR; Huq F; Quinn JMW; Holsinger RMD; Gov E; Moni MA
Genomics; 2020 Mar; 112(2):1290-1299. PubMed ID: 31377428
[TBL] [Abstract][Full Text] [Related]
15. Integrated miRNA-Seq and mRNA-Seq Study to Identify miRNAs Associated With Alzheimer's Disease Using Post-mortem Brain Tissue Samples.
Li QS; Cai D
Front Neurosci; 2021; 15():620899. PubMed ID: 33833661
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of microRNA-4487/6845-3p in Alzheimer's disease pathologies is induced by Aβ25-35 triggered in SH-SY5Y cell.
Hu L; Zhang R; Yuan Q; Gao Y; Yang MQ; Zhang C; Huang J; Sun Y; Yang W; Yang JY; Min ZL; Cheng J; Deng Y; Hu X
BMC Syst Biol; 2018 Dec; 12(Suppl 7):119. PubMed ID: 30547775
[TBL] [Abstract][Full Text] [Related]
17. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.
Sørensen SS; Nygaard AB; Christensen T
Transl Neurodegener; 2016; 5():6. PubMed ID: 26981236
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-134-5p inhibition rescues long-term plasticity and synaptic tagging/capture in an Aβ(1-42)-induced model of Alzheimer's disease.
Baby N; Alagappan N; Dheen ST; Sajikumar S
Aging Cell; 2020 Jan; 19(1):e13046. PubMed ID: 31625272
[TBL] [Abstract][Full Text] [Related]
19. Role of Post-Transcriptional Control of Calpain by miR-124-3p in the Development of Alzheimer's Disease.
Zhou Y; Deng J; Chu X; Zhao Y; Guo Y
J Alzheimers Dis; 2019; 67(2):571-581. PubMed ID: 30584150
[TBL] [Abstract][Full Text] [Related]
20. miR-149-5p inhibition reduces Alzheimer's disease β-amyloid generation in 293/APPsw cells by upregulating H4K16ac via KAT8.
Chen F; Chen H; Jia Y; Lu H; Tan Q; Zhou X
Exp Ther Med; 2020 Nov; 20(5):88. PubMed ID: 32973937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
